Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.36 |
| ▸ | DDR1 | Q08345 | 3/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.35 |
| ▸ | MGAT2 | Q10469 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16243409 | 0.89 | PTGES (0.35) | EPHX2NR1H4DDR1LMNACA1 | |
| SCHEMBL15492050 | 0.89 | PTGES (0.35) | EPHX2NR1H4DDR1LMNACA1 | |
| SCHEMBL981696 | 0.87 | EPHX2 (0.35) | EPHX2NR1H4DDR1TRPV1LMNA | |
| SCHEMBL979609 | 0.83 | TRPV1 (0.34) | EPHX2NR1H4DDR1TRPV1LMNA | |
| SCHEMBL3625711 | 0.82 | GPBAR1 (0.32) | — | |
| SCHEMBL980954 | 0.81 | TRPV1 (0.35) | EPHX2NR1H4TRPV1LMNACA1 | |
| SCHEMBL980463 | 0.80 | — | — | |
| SCHEMBL979491 | 0.80 | HSD11B1 (0.35) | EPHX2NR1H4LMNACA1CA2 | |
| SCHEMBL981224 | 0.80 | TRPV1 (0.36) | EPHX2NR1H4TRPV1LMNACA1 | |
| SCHEMBL1857748 | 0.79 | LMNA (0.41) | EPHX2LMNAP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318757-B2 | Substituted isoxazoline compound and pest control agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-20110009438-A1 | SUBSTITUTED ISOXAZOLINE COMPOUND AND PEST CONTROL AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009438-A1 | SUBSTITUTED ISOXAZOLINE COMPOUND AND PEST CONTROL AGENT | CCR10, H1-10, CCL11 | EPHX2 2604/4885NR1H4 1645/4885DDR1 2835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.